These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8636318)

  • 1. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM).
    Gibson JM; Westwood M; Young RJ; White A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):860-3. PubMed ID: 8636318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.
    Heald AH; Siddals KW; Fraser W; Taylor W; Kaushal K; Morris J; Young RJ; White A; Gibson JM
    Diabetes; 2002 Aug; 51(8):2629-36. PubMed ID: 12145180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.
    Mohamed-Ali V; Pinkney JH; Panahloo A; Cwyfan-Hughes S; Holly JM; Yudkin JS
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):221-8. PubMed ID: 10396366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.
    Laughlin GA; Barrett-Connor E; Criqui MH; Kritz-Silverstein D
    J Clin Endocrinol Metab; 2004 Jan; 89(1):114-20. PubMed ID: 14715837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor axis and plasma lipid levels in the elderly.
    Ceda GP; Dall'Aglio E; Magnacavallo A; Vargas N; Fontana V; Maggio M; Valenti G; Lee PD; Hintz RL; Hoffman AR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):499-502. PubMed ID: 9467564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes.
    Narayanan RP; Fu B; Oliver RL; Siddals KW; Donn R; Hudson JE; White A; Laing I; Ollier WE; Heald AH; Gibson JM
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):468-75. PubMed ID: 24081183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.